For the joint production of the Russian vaccine against the Sputnik V coronavirus in the European Union, registration of a European regulator will be required. This condition was called by German Chancellor Angela Merkel, her words are quoted by TASS.
The Chancellor recalled that Russia has already applied to the European Medicines Agency (EMA) to register the drug. “If this vaccine gets EMA approval, then we can talk about joint production and use,” Merkel said.
It became known on January 20 that Moscow had applied for registration of Sputnik V in the European Union. The experts of the European regulator will send recommendations to the drug developers within 7-10 days.
Hungary was the first in the European Union to approve the Sputnik V vaccine. The Russian drug is also registered in Belarus, Serbia, Argentina, Bolivia, Algeria, Palestine, Venezuela, Paraguay and Turkmenistan.
